Expanding Indications For The New Macrolides, Azalides, and by Zinner, Stephen H. Zinner, J. Acar

By Zinner, Stephen H. Zinner, J. Acar

This well timed quantity specializes in significant accomplishments within the learn and improvement of latest antibiotics and their purposes in medical drugs in addition to addresses difficulties not easy medical and laboratory researchers world wide.

Show description

Read or Download Expanding Indications For The New Macrolides, Azalides, and Streptogramins (Infectious Disease and Therapy) PDF

Best nonfiction_4 books

Estonia: implementing the EU accession agenda

"Economic integration that ends up in the convergence of earning and dwelling criteria is on the middle of the ecu accession procedure. the idea is that alternate integration mixed with institutional harmonization will bring about sustainable capital flows from eu Union member international locations to acceding international locations .

Extra resources for Expanding Indications For The New Macrolides, Azalides, and Streptogramins (Infectious Disease and Therapy)

Sample text

67. 68. 69. 70. 71. 72. 73. 74. 75. encephalitis in patients with AIDS. Antimicrob Agents Chemother1991;35: 2049-2052. Markham A, Faulds D. Roxithromycin. An update of its antimicrobial activity, pharmacokinetic properties and therapeutic use. Drugs 1994;48(2):297326. Schonwald S , Car V, Kuzman I, Mihaljevic F. Comparison of roxithromycin and erythromycin in the treatment of atypical pneumonias. (Abstract) 16th International Congress of Chemotherapy, Jerusalem, 1989. Cooper BC, Mullins PR, Jones MR.

The overall safety of oral roxithromycin in paediatric clinical studies. Infection 1995;23 (suppl 1):25-27. Okamoto S, Haruma K, Kawaguchi H, Inoue K, SumiiK,Kajiyama G, Vemura N, Sanuki E. Study on eradication of Helicobacter pylori by the combination useof roxithromycin, bismuth subnitrate, and omeprazole. 18th International Congress of Chemotherapy Stockholm, 1993; abstr. 960. Bircher Gelzer D, Rufli T. A double blind comparisonof two treatment regimens. (Abstract) 16th International Congress of Chemotherapy, Jerusalem, 1989.

Perfringens C . urealyticum H . 06 ~ Source: Data based on Refs. 3, 29, 51, and 62. includes Haemophilus ducreyi. Azithromycin is the most active agent against N. gonorrhoeae whereas roxithromycin offers no microbiological advantage over erythromycin against this group of pathogens. Although the macrolides are inactive against common gram-negative pathogens, Cumpylobucter jejuni is susceptible. Furthermore, Helicobacter pylori is also susceptible, with clarithromycin showing the greatest activity (1).

Download PDF sample

Rated 4.20 of 5 – based on 49 votes

About admin